To analyze the synergistic up-regulation of IDO1 by the HH/GLI and IL6/STAT3 signaling pathways, we also looked into an RNA-seq data set of human BCC patient as well as normal skin samples (Bonilla et al.)[21]. The gene discussed is IDO1; the disease is skin basal cell carcinoma.